[ad_1]
Company Submits Formal Application for Urgent Approval of Pfizer Coronavirus Vaccine
Pfizer announced Friday that it had filed a lawsuit against US Regulators (FDA) to allow the urgent use of your vaccine against it coronavirus and thus begins the countdown for approval and circulation. The move comes after Pfizer and BioNTech announced that their vaccine was 95% effective in protecting patients from the coronavirus.
According to CNBC, the companies claim that the protection the vaccine provides and its efficacy rates will earn it the coveted approval by the US Food and Drug Administration even before final testing is completed.
HELLAS
This is Albert Bourla: his friends talk to ethnos.gr about the CEO of Pfizer
This is Albert Bourla: his friends talk to ethnos.gr about the CEO of Pfizer
In addition to submitting approval to this agency, Pfizer and Biontech have begun applying for approval of their vaccine in Europe and the UK. “Our work to provide a safe and effective vaccine is more urgent than ever,” he said in a statement. Albert Burla.
Hours after approval, distribution of the vaccine will begin.
In a matter of a few hours the vaccine distribution from Pfizer from the moment of approval. This revelation was made on Thursday the director of the pharmaceutical company Albertos Boulas speaking with Sky News. Mr. Bourla also noted that more than 20 million doses of vaccine have been produced so far and production continues.
According to his boss Pfizer He stressed that the company is ready to send doses of the COVID-19 vaccine “within a few hours” of receiving official approval. At the same time, it will seek permission from regulators around the world “very, very soon, in a few days” and will immediately begin shipping the first of 20 million doses of vaccine that have already been produced.
He added that the quotas will be sent to the countries as soon as the health regulatory authorities allow. In addition, the probability of “regulating the situation” will increase. According to Mr. Μπουρλά people must be “patient” because demand will exceed supply.
“The light is real, there is light at the end of the tunnel,” he said, adding that “I think the second half of 2021 will be a very different experience for many of us.” His statements come shortly after the completion of his study. “Phase 3”, of the vaccine for coronavirus, created in collaboration with the German company BioNTech.
Teasing’s message to young people
THEAlbert bourla, its CEO Pfizer, an expat from Thessaloniki heads the pharmaceutical company Pfizer which appears to be changing the data in the battle against its pandemic coronavirus.
THE Albert bourla, who has worked on five different continents, lived in eight different cities and worked with very talented people from all over the world, spoke from his own professional experience and sent a strong message to students to set a very high bar.
«I never forgot where I started and where I owe it. Aristotle’s contribution to my success extends far beyond my scientific education. Aristotle shaped my character and completed my personality in the most critical decade of my life, between the ages of 18 and 28. I acquired cultures, values and ideals, ”says Mr. Bourlas.
“To the students I would like to express an exhortation: do not limit your dreams, this world can become yours, to achieve the dreams of tomorrow, focus on doing the job perfectly today, make mediocrity your enemy. Set the bar very high every day and when you overcome it, set the bar higher, “he concluded. Albert bourla.
